Deals

Weekly Digest – July 2025 Weekly Digest – July 2025 03 July 2025: Elevation Oncology ends license agreement with CSPC Megalith Biopharmaceutical Elevation Oncology has terminated its license agreement with CSPC Megalith Biopharmaceutical for EO-3021, effective June 26, 2025 EO-3021 […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – July 2025 Weekly Digest – July 2025 02 July 2025: Biokin, having landed BMS deal, posts Phase 3 cancer win for bispecific ADC Biokins Phase 3 trial of its bispecific ADC, Izalontamab brengitecan (iza-bren), met at least […]

by Sandhya Ramalingam

Continue Reading